Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (UK)

Index « Auteurs » - entrée « Dionyssios Katsaros »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dionysios E. Raitsos < Dionyssios Katsaros < Dipak Kotecha  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000787 (2016) Stephanie M. De Boer [Pays-Bas] ; Melanie E. Powell [Royaume-Uni] ; Linda Mileshkin [Australie] ; Dionyssios Katsaros [Italie] ; Paul Bessette [Canada] ; Christine Haie-Meder [France] ; Petronella B. Ottevanger [Pays-Bas] ; Jonathan A. Ledermann [Royaume-Uni] ; Pearly Khaw [Australie] ; Alessandro Colombo [Italie] ; Anthony Fyles [Canada] ; Marie-Helene Baron [France] ; Henry C. Kitchener [Royaume-Uni] ; Hans W. Nijman [Pays-Bas] ; Roy F. Kruitwagen [Pays-Bas] ; Remi A. Nout [Pays-Bas] ; Karen W. Verhoeven-Adema [Pays-Bas] ; Vincent T. Smit [Pays-Bas] ; Hein Putter [Pays-Bas] ; Carien L. Creutzberg [Pays-Bas]Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.
000B87 (2016) Evelyn Despierre [Belgique] ; Ignace Vergote [Belgique] ; Ryan Anderson [États-Unis] ; Corneel Coens [Belgique] ; Dionyssios Katsaros [Italie] ; Fred R. Hirsch [États-Unis] ; Bram Boeckx [Belgique] ; Marileila Varella-Garcia [États-Unis] ; Annamaria Ferrero [Italie] ; Isabelle Ray-Coquard [France] ; John A. Green [Royaume-Uni] ; Christopher Steer [Australie] ; Els M J J. Berns [Pays-Bas] ; Antonio Casado [Espagne] ; Diether Lambrechts [Belgique] ; Antonio Jimeno [États-Unis]Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.
001681 (2014) Ignace B. Vergote [Belgique] ; Antonio Jimeno [États-Unis] ; Florence Joly [France] ; Dionyssios Katsaros [Italie] ; Corneel Coens [Belgique] ; Evelyn Despierre [Belgique] ; Christian Marth [Autriche] ; Marcia Hall [États-Unis] ; Christopher B. Steer [Australie] ; Nicoletta Colombo [Italie] ; Anne Lesoin [France] ; Antonio Casado [Espagne] ; Alexander Reinthaller [Autriche] ; John Green [Royaume-Uni] ; Martin Buck [Australie] ; Isabelle Ray-Coquard [France] ; Annamaria Ferrero [Italie] ; Laure Favier [France] ; Nick Simon Reed [Royaume-Uni] ; Hervé Cure [France] ; Eric Pujade-Lauraine [France]Randomized Phase III Study of Erlotinib Versus Observation in Patients With No Evidence of Disease Progression After First-Line Platin-Based Chemotherapy for Ovarian Carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup Study

List of associated KwdEn.i

Nombre de
documents		Descripteur
1Adenocarcinoma, Clear Cell (radiotherapy)
1Adenocarcinoma, Clear Cell (secondary)
1Adenocarcinoma, Clear Cell (therapy)
1Aged
1Antineoplastic Combined Chemotherapy Protocols (adverse effects)
1Antineoplastic agent
1Cancerology
1Carboplatin (administration & dosage)
1Case-Control Studies
1Chemoradiotherapy, Adjuvant (adverse effects)
1Cisplatin (administration & dosage)
1Comparative study
1Cystadenocarcinoma, Serous (radiotherapy)
1Cystadenocarcinoma, Serous (secondary)
1Cystadenocarcinoma, Serous (therapy)
1Endometrial Neoplasms (pathology)
1Endometrial Neoplasms (radiotherapy)
1Endometrial Neoplasms (therapy)
1Erlotinib
1Europe
1Female
1Female genital diseases
1First line treatment
1Follow-Up Studies
1Gastrointestinal Diseases (diagnosis)
1Gastrointestinal Diseases (etiology)
1Hematologic Diseases (diagnosis)
1Hematologic Diseases (etiology)
1Human
1Humans
1Lymphatic Metastasis
1Malignant tumor
1Middle Aged
1Neoplasm Grading
1Neoplasm Invasiveness
1Neoplasm Staging
1Nervous System Diseases (diagnosis)
1Nervous System Diseases (etiology)
1Ovary cancer
1Ovary carcinoma
1Paclitaxel (administration & dosage)
1Phase III trial
1Prognosis
1Quality of Life
1Radiotherapy, Adjuvant (adverse effects)
1Randomization
1Research
1Survival Rate

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Dionyssios Katsaros" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Dionyssios Katsaros" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Dionyssios Katsaros
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024